Skip to main content
SleepCited

Screening natural raw materials and product development for improving insomnia based on network pharmacology and data mining.

Lizhi Yue, Qian Jiao, Junxiang Li, Yi Lu, Meiting Yi et al.
Other Medicine 2026

Study Design

Study Type
laboratory/in vitro
Intervention
Screening natural raw materials and product development for improving insomnia based on network pharmacology and data mining. Pinghe Sleep Aromatherapy Product containing sandalwood, lime, angelica sinensis, yilan, sage, and l
Effect Direction
Positive
Risk of Bias
Unclear

Abstract

Insomnia, as one of the most common sleep problems, seriously affects the normal life and work of individuals. Aromatherapy is regarded as a promising alternative medicine for improving sleep quality. Based on network pharmacology and data mining, this study screened natural raw materials for improving insomnia. Then, we developed an aromatherapy product informed by the screening results and investigated its mechanism for improving insomnia through network pharmacology. Five core insomnia targets were identified through literature. 1600 candidate compounds and 1757 candidate herbs related to the target were matched using HERB and TCMSP databases. By comparing with the Catalogue of Used Cosmetic Materials (2021 edition), 597 kinds of usable candidate materials were selected, including 85 raw materials related to target MTNR1A, 86 raw materials related to target MTNR1B, 120 raw materials related to target HTR1A, 7 raw materials related to target GABRB2, and 582 raw materials related to target GABRA1. Then based on the screening results, we selected sandalwood, lime, angelica sinensis, yilan, sage and lavender to design Pinghe Sleep Aromatherapy Product to improve insomnia. Network pharmacological analysis revealed that the main ingredients of the Pinghe Sleep Aromatherapy Product are beta-sitosterol, stigmasterol, isorhamnetin, luteolin, tanshinone IIA, D-limonene, and linalool. It exerts improvement effects by influencing targets such as IL6, TNF, AKT1, CASP3, TP53, and VEGFA, regulating signaling pathways such as AGE-RAGE, neuroactive ligand-receptor interactions, the HIF-1 signaling pathway, and the calcium signaling pathway. This study provides an idea of raw material screening and product development, which can save product development cost and shorten product development cycle by using network pharmacology and data mining.

Full Text

1. Introduction

Insomnia refers to a subjective experience of inadequate sleep duration or quality despite suitable sleep opportunities and sleep environments and affects social functioning during the day. The main symptoms include difficulty falling asleep (sleep latency >30 minutes), sleep maintenance disorder (≥2 awakenings throughout the night), early waking, decreased sleep quality and total sleep time (usually <6.5 hours), accompanied by daytime dysfunction. Daytime dysfunction caused by insomnia mainly includes fatigue, depression or irritation, physical discomfort, cognitive impairment, etc.[1] Long-term insomnia affects an individual’s normal life and work, increases the risk of various health problems,[2] and may impair brain neuroplasticity and stress immune pathways, leading to mental disorders.[3] It may even cause serious accidents and endanger people’s life safety.[4] Insomnia is one of the most common sleep problems and is clinically common, occurring in up to 50% of primary care patients. Insomnia can occur independently or in conjunction with other diseases or mental health disorders.[5] People with anxiety or depression, women, the elderly, and people with chronic conditions such as asthma and chronic obstructive pulmonary disease are at greater risk for insomnia.[6] Restoring good sleep continuity and longer sleep duration can improve sleep-related functions, including mood, memory, cognition, weight, blood pressure, glucose regulation, amyloid beta clearance, and immune function.[5] Many sleep-regulating substances are involved in circadian rhythms and sleep regulation. Studies have shown that endogenous molecules related to insomnia mainly include γ-aminobutyric acid (GABA), adenosine, serotonin, melatonin, and prostaglandin D2.[7] At present, the main intervention methods for insomnia include drug therapy, psychological therapy, physical therapy, and Chinese ethnic medicine therapy. The short-term efficacy of drugs for insomnia has been confirmed by clinical trials, but long-term application still needs to bear the potential risks of drug adverse reactions, addiction and so on. Aromatherapy, massage, and other methods also have their unique application advantages in the treatment and improvement of insomnia.[1]

Aromatherapy is regarded as a promising alternative medicine for improving sleep quality. Aromatic components have the function of nourishing the heart and calming the mind, regulating qi and resolving depression, and have a long history of use in China.[8,9] As a daily consumer product, aromatic products have the advantages of frequent use and long-term use without side effects. Network pharmacology is a scientific idea and research strategy based on high-throughput omics data analysis, computer virtual computing, biological information network construction and network topology analysis strategies and technologies.[10] This study was based on network pharmacology and data mining to screen Chinese characteristic natural raw materials for improving insomnia. Then based on the screening results, we designed Pinghe Sleep Aromatherapy Product (PSAP), and used network pharmacology to explore the key components and core targets of PSAP in improving insomnia, as well as the action pathways of components and targets. Our findings provide novel insight and data reference for the development of aromatic products for improving insomnia.

2. Materials and methods

2.1. Network pharmacology screens natural raw materials for improving insomnia

2.1.1. Collect potential targets for insomnia

The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) (https://www.tcmsp-e.com/tcmsp.php) was searched with “insomnia” and “chronic insomnia” as keywords, and the targets of insomnia were collected, and then the main targets of insomnia were determined by supplementing the results of literature search.

2.1.2. Screening candidate compounds and Chinese herbs

Compounds and Chinese herbs related to the target were collected by searching the TCMSP platform and the High-throughput Experimental and Reference guided database of traditional Chinese medicine (HERB) (http://herb.ac.cn), and repetitive components were deleted to obtain the target-related compounds set and Chinese herbs set.

2.1.3. Selection of available raw materials for candidate cosmetics

The above Chinese herbal medicine raw materials were compared with the Catalogue of Used Cosmetic Raw Materials (2021 edition) one by one to screen the available cosmetic raw materials.

2.1.4. Network construction

The network diagram of target-compound – raw material is constructed by using Cytoscape 3.9.1 (California), and the topological parameters of nodes in the network were calculated. According to the degree value of each node in the network, the key node was determined, and the core compound and the available raw material were determined.

2.2. Network pharmacological analysis of the improvement of insomnia by PSAP

2.2.1. Insomnia related target screening

Three databases were used to screen the potential targets of insomnia. They were the TCMSP (https://old.tcmsp-e.com/tcmsp.php), Genecards database (https://www.genecards.org/) and Disgenet database (http://www.disgenet.org). Merged the collected targets and deleted duplicate data.

2.2.2. Prediction of target of PSAP

PSAP is composed of sandalwood, lime, angelica sinensis, yilan, sage and lavender. Potential targets of these raw material were screened using TCMSP (https://old.tcmsp-e.com/tcmsp.php) and supplemented by literature search using PubMed. Merged the collected targets and deleted duplicate data.

2.2.3. Prediction of therapeutic targets of PSAP in the improving of insomnia

The online Venn analysis tool (https://bioinfogp.cnb.csic.es/tools/venny/) was used to calculate and draw custom Venn diagrams to obtain the intersection targets of PSAP in the improving of insomnia.

2.2.4. Construction of the PPI network and screening of core targets

Import the intersection target into the Search Tool for Recurring Instances of Neighbouring Genes platform (https://cn.string-db.org) for analysis. The species is limited to Homo sapien. Create a protein–protein interaction (PPI) network, download the PPI network, and import into Cytoscape 3.9.1 to perform core target analysis based on Centiscape 2.2 (California) plug-in. The core target whose closeness, betweenness and degree are greater than the central value is the core target.

2.2.5. GO and KEGG pathway analysis

Import the intersection targets into the Metascape database (https://metascape.org/gp/index.html#/main/step1) for gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis. The organism selected was Homo sapiens. The significance level was set to P < .05, and the top 20 analysis results were plotted respectively.

3. Results

3.1. Network pharmacology screens natural raw materials for improving insomnia

3.1.1. Target acquisition

Through literature research and TCMSP database search, 5 main targets for insomnia were identified as shown in Table 1.

3.1.2. Acquisition of candidate compounds and Chinese herbs

HERB and TCMSP were used to retrieve components associated with 5 targets. Considering that aromatic products are used for external use only and are not used in the same way as drugs, they are not suitable for the pharmacokinetic parameters and Lipinski rule referenced in drug screening.[11] In this study, no screening parameters were set when screening compounds, and all the compounds related to the target were collected, and a total of 1600 compounds were obtained. HERB and TCMSP were used to search the Chinese herbs related to the compounds. A total of 12,950 Chinese herbs were collected, and 1757 kinds of Chinese herbs were obtained after weight removal.

3.1.3. Availability of raw materials for candidate cosmetics

The above 1757 candidate Chinese herbs were compared with the raw materials in the Catalogue of Used Cosmetics Raw Materials (2021 edition). In the screening, the common name and alias of the raw material should be considered comprehensively to avoid omission. A total of 597 candidate raw materials for improving insomnia were obtained.

3.1.4. Target-compound – raw material network construction

3.1.4.1. Network construction of target MTNR1A

Through screening, 16 compounds related to the target MTNR1A, and 85 kinds of related raw materials were obtained. The network diagram constructed by the target, candidate compounds and candidate raw materials was shown in Figure 1. According to the size of the degree value, take the top 10 compounds and candidate raw materials to make a bar chart, as shown in Figure 2A and B. The top 5% candidate raw materials with the degree value are taken as the core raw materials. The core raw materials related to the target MTNR1A in terms of degree value were root of membranous milkvetch, reed rhizome, rhizome of gaint knotweed, sanchi, medicil evodia fruit. The annotations of the compounds are shown in Table 2.

3.1.4.2. Network construction of target MTNR1B

Through screening, 16 compounds related to the target MTNR1B, and 86 kinds of related candidate raw materials were obtained. The network diagram constructed by the target, candidate compounds and candidate raw materials was shown in Figure 3. According to the size of the degree value, take the top 10 compounds and candidate raw materials to make a bar chart, as shown in Figure 4A and B. The annotations of the compounds are shown in Table 3. The top 5% candidate raw materials with the degree value were taken as the core raw materials. The core raw materials related to the target MTNR1B in terms of degree value were root of membranous milkvetch, reed rhizome, rhizome of gaint knotweed, sanchi, medicil evodia fruit. The results of core material screening were the same as those of target MTNR1A.

3.1.4.3. Network construction of target HTR1A

Through screening, 48 compounds related to the target HTR1A, and 120 kinds of related candidate raw materials were obtained. The network diagram constructed by the target, candidate compounds and candidate raw materials was shown in Figure 5. According to the size of the degree value, take the top 10 compounds and candidate raw materials to make a bar chart, as shown in Figure 6A and B. The top 5% candidate raw materials with the degree value were taken as the core raw materials. The core raw materials related to the target HTR1A in terms of degree value were Chinese caterpillar fungus, myrrh, lucid Ganoderma, fruit of chinese wolfberry, sanchi, medicil evodia fruit. The annotations of the compounds are shown in Table 4.

3.1.4.4. Network construction of target GABRB2

After screening, 3 compounds related to the target GABRB2, and 7 kinds of related candidate raw materials were obtained. The network diagram constructed by the target, candidate compounds and candidate raw materials was shown in Figure 7. The annotations of the compounds are shown in Table 5. The top 5% of candidate raw materials were taken as the core raw materials, and it could be seen that rhizome of gaint knotweed was the potential core candidate raw material of target GABRB2.

3.1.4.5. Network construction of target GABRA1

1264 compounds related to GABRA1, and 582 kinds of candidate raw materials were obtained by screening, and the network diagram of targets, candidate compounds and candidate raw materials was constructed. The candidate raw materials with the top 5%-degree value were taken as the core raw materials. Fresh ginger, chrysanthemum flower, myrrh, root of chinese thorowax, villous amomum fruit, perilla frutescens, coriandri sativi herba, chuanxiong rhizome, peppermint, officinal magnolia equivalent plant: magnolia bilo, leaf of argy wormwood, all-grass of haichow elsholtzia, root and rhizome of incised notoptergium, all-grass of fineleaf schizonepeta, common aucklandia root, root of ligulilobe sage, root of divaricate saposhnikovia, shrub chastetree fruit, medicil evodia fruit, honeysuckle flower, sweet wormwood herb, dried ginger, oily wood of agalloch eaglewood, taproot angelica, cassia bark, leafy twigs of oriental arborvitae, loquat leaf, fructus corni, combined spicebush root, ginkgo folium were the core raw materials. The other top 50 ingredients were shown in Table 6.

3.2. Network pharmacological analysis of the improvement of insomnia by PSAP

3.2.1. Target acquisition

1302 targets of insomnia were obtained through TCMSP, Disgenet and Genecard. 137 targets of PSAP were obtained through TCMSP, Uniprot and PubMed. After taking the intersection, 62 intersection targets were obtained. As shown in Figure 8.

3.2.2. String analysis

A total of 62 interse ction targets are imported into the Search Tool for Recurring Instances of Neighbouring Genes platform for core target analysis. A total of 25 core targets are obtained as shown in Figure 9 and Table 7.

3.2.3. GO and KEGG analysis

GO enrichment was conducted on the core targets of the PSAP for improving insomnia. The top 20 items were selected for analysis based on the enrichment intensity (Figure 10A–C). The molecular functions are enriched in neurotransmitter receptor activity, excitatory extracellular ligand-gated ion channels, neurotransmitter gated ion channel activity involved in regulating postsynaptic membrane potential, inhibitory extracellular ligand-gated ion channels, etc. In biological processes, it is enriched in responses to drugs, responses to xenogenic stimuli, positive regulation of gene expression, and positive regulation of mitogen-activated protein kinase activity, etc. The whole of the plasma membrane, neurons, the whole of the presynaptic membrane, the plasma membrane, synapses, etc are enriched in the cell composition.

KEGG enrichment analysis was conducted on the core targets of the PSAP for improving insomnia. The top 20 pathways were selected for analysis based on enrichment intensity (Fig. 10D). The KEGG pathways closely related to insomnia include the cancer pathway, the advanced glycation end product-receptor for advanced glycation end products (AGE-RAGE) signaling pathway in diabetic complications, lipids and atherosclerosis, neuroactive ligand-receptor interactions, the hypoxia inducible factor-1 (HIF-1) signaling pathway, and the calcium signaling pathway, etc.

3.2.4. Network construction

Construct the PSAP-key components-insomnia key targets relationship network diagram, as shown in Figure 11. The connections between nodes represent the links among key raw materials, key components, and core targets. As can be seen from the figure, the PSAP improved insomnia through multiple pathways and targets.

4. Discussion

Through network analysis, the potential core candidate raw materials related to MTNR1A and MTNR1B were root of membranous milkvetch, reed rhizome, rhizome of gaint knotweed, sanchi, medicil evodia fruit. Potential core candidate raw materials related to target HTR1A were chinese caterpillar fungus, myrrh, lucid Ganoderma, fruit of chinese wolfberry, sanchi, medicil evodia fruit. A potential core candidate raw material related to GABRB2 was rhizome of gaint knotweed. Potential core candidate raw materials related to the target GABRA1 were fresh ginger, chrysanthemum flower, myrrh, root of chinese thorowax, villous amomum fruit, perilla frutescens, coriandri sativi herba, chuanxiong rhizome, peppermint, officinal magnolia equivalent plant: magnolia bilo, leaf of argy wormwood, all-grass of haichow elsholtzia, root and rhizome of incised notoptergium, all-grass of fineleaf schizonepeta, common aucklandia root, root of ligulilobe sage, root of divaricate saposhnikovia, shrub chastetree fruit, medicil evodia fruit, honeysuckle flower, sweet wormwood herb, dried ginger, oily wood of agalloch eaglewood, taproot angelica, cassia bark, leafy twigs of oriental arborvitae, loquat leaf, fructus corni, combined spicebush root, ginkgo folium.

The potential core candidate raw materials of target MTNR1A and target MTNR1B are the same. The potential core candidate raw materials shared by target MTNR1A, target MTNR1B and target HTR1A were sanchi, medicil evodia fruit. The potential core candidate raw material shared by target MTNR1A, target MTNR1B and target GABRB2 was rhizome of gaint knotweed. The potential core candidate raw material shared by target MTNR1A, target MTNR1B, target HTR1A and target GABRA1 was medicil evodia fruit.

Melatonin is an important endocrine hormone, mainly secreted by the pineal gland and the retina, and acts by binding to the melatonin receptor, which has the function of regulating physiological rhythm, sleep, and reproduction. Studies have shown that the MTNR1A and the MTNR1B is expressed on the surface of nervous system, pancreatic β cells, liver, skeletal muscle, adipose tissue, and ovarian granulosa cells.[12,13] The variation of melatonin receptor is the cause of human sleep disorders, polycystic ovary syndrome, gestational diabetes, recurrent kidney stones and other diseases.[14] Ebisawa et al[15] found that there were 7 mutations in the MTNR1A gene between patients with circadian dysrhythmic sleep disorder and healthy people. Park et al[16] found that SNP rs2119882 in the human MTNR1A promoter region is associated with schizophrenia and its resulting insomnia. MTNR1B receptor is involved in the pathophysiological and pharmacological processes of sleep disorders, anxiety, depression, Alzheimer disease, and pain.[17]

Serotonin, also known as 5-hydroxytryptamine, plays an important role in the regulation of animal behavior. HTR1A is an inhibitory G-protein-coupled receptor that is expressed on both serotonin and non-serotonin neurons in mammals.[18] Studies have shown that HTR1A plays an important role in mental disorders[19] and is the main target of most antidepressant drugs.[20] When activated by serotonin, HTR1A can regulate mood and relieve anxiety.[18] Wang et al found that Chaihu-Longgu-Muli Decoction can enhance the expression of HTR1A, regulate the secretion of neurotransmitters, and have sedative and hypnotic effects.[21] Sun et al[22] found that Banxia-Houpo decoction remedy ameliorates corticosterone-induced depressive behaviors in mice via targeting 5-hydroxytryptamine receptor 1A signaling.

Gamma-aminobutyric acid A receptor (GABAAR) is a ligand-gated chloride ion channel protein that mediates the main inhibitory function of the central nervous system, and its dysfunction plays an important role in the etiology of epilepsy.[23,24] GABRA1, a member of the GABAAR subunit family, encodes the α1 subunit of GABAAR, and its coding gene is located on human chromosomes 5q34-q35, which is related to mood disorders.[25] The GABRB1 gene encodes the β1 subunit of GABAAR, which is responsible for mediating inhibitory neurotransmission in the thalamus.[26] Studies have found that downregulation of the GABA receptor subunits is positively correlated with schizophrenia.[27] Upregulating the expression of γ-aminobutyric acid receptors can increase the opening frequency of chloride ion channels and play a sedative and hypnotic role.[28]

Root of membranous milkvetch is a representative drug for supplementing qi and strengthening surface, and called “the length of tonic medicine” in Compendium of Materia Medica.[29] Modern studies have shown that root of membranous milkvetch has many biological activities, such as wound healing, immune regulation, antitumor, liver protection, antimutagenesis and so on.[30] As the most widely used qi tonic drug in clinic, root of membranous milkvetch can be used to modulate immune function[31] and is a common drug for improving insomnia.[32] Wang et al[33] found that astragalus could improve the cerebral artery blood flow speed, alleviate cerebral tissue ischemia, and prolong sleep time.

Reed rhizome is a grass plant of the genus Phragmites communis Trin. It is a variety collected in the “Chinese Pharmacopoeia.” It is a commonly used traditional Chinese medicine with the same origin of medicine and food. It is cold in nature and sweet in taste and has the effects of clearing heat and promoting fluid, eliminating irritability, stopping vomiting and diuresis.[34] Modern pharmacological studies have shown that reed rhizome has antioxidant, hypoglycemic, antitumor, liver protection and other effects.[35] The lignan glycosides, flavonoids and phenylpropanoids contained in reed rhizome have antioxidant activity and α-glucosidase inhibitory activity.[36]

Rhizome of gaint knotweed is the dried rhizome and root of Polygonum cuspidatum sieb.et Zucc. containing polydatin, resveratrol, emodin, etc.[37] Rhizome of gaint knotweed has pharmacological effects such as anti-inflammation, antioxidation, regulating blood lipids and improving cognition.[38,39] Rhizome of gaint knotweed can significantly improve the neurological dysfunction of mice with traumatic brain injury, alleviate brain edema and reduce neuronal degeneration, enhance neuronal autophagy and inhibit neuronal apoptosis.[40]

Sanchi is a dried root and rhizome of Panax notoginseng (burkill) F.H. Chenexc.Chow&W.G.Huang, which has the effects of dispelling stasis, stopping bleeding, reducing swelling and relieving pain.[41] Sanchi mainly contains a variety of pharmacodynamic components such as total notoginseng saponins, notoginseng pigments and flavonoids,[42] which can promote blood circulation, stop bleeding, antithrombus and enhance body immunity.[43]

Medicil evodia fruit is a genus of rutaceae, mainly distributed in the south of Qinling Mountains in China, especially in Yungui and Chuanshu regions, and uses dried and nearly ripe fruits as medicine.[44] The taste is pungent, bitter, hot, and small poison.[34] Medicil evodia fruit mainly contains alkaloids, picrogens, flavonoids and other chemical components.[45] Studies have shown that medicil evodia fruit can reduce the levels of inflammatory factors such as tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β),[46] increase the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in brain, and reduce the production of free radicals, reduce the content of nitric oxide (NO) and the activities of nitric oxide synthase (NOS) and inducible nitric oxide synthase (iNOS).[47]

The plant raw materials mentioned above may have the potential to improve insomnia. Plant raw materials with multiple targets of action may be important because of their potential broad-spectrum effects on insomnia. Combining multiple plant raw materials associated with multiple targets may be an improvement strategy.

Based on the screening results, we selected sandalwood, lime, angelica sinensis, yilan, sage and lavender to design PSAP to improve insomnia. Analysis reveals that the medicinal ingredients in the PSAP such as beta-sitosterol, stigmasterol, isorhamnetin, luteolin, tanshinone IIA, D-limonene, and linalool can act on target genes such as IL6, TNF, AKT1, CASP3, TP53, and VEGFA, regulate signaling pathways such as AGE-RAGE, neuroactive ligand-receptor interactions, the HIF-1 signaling pathway, and the calcium signaling pathway, etc, thereby exerting the effect of improving insomnia. Its mechanism of action involves multiple pharmacological components, target genes and signaling pathways.

5. Conclusion

In this study, a target-compound raw material network was constructed based on network pharmacology and data mining. Core natural raw materials that may help to improve insomnia were identified by network, providing a theoretical basis for the development of aromatic products to improve insomnia. Based on the screening results, we developed the PSAP. However, the potential target genes and signaling pathways of the PSAP explored in this study for improving insomnia still need to be further verified by relevant experiments. But in general, this study provides the data foundation for product development, and provides an idea of raw material screening and product development. Using network pharmacology and data mining, product development costs can be saved, and product development cycle can be shortened.

Author contributions

Conceptualization: Yan Jia.

Data curation: Qian Jiao.

Formal analysis: Meiting Yi.

Project administration: Congfen He.

Writing – original draft: Lizhi Yue.

Writing – review & editing: Junxiang Li, Yi Lu.

Abbreviations:AGE-RAGE

advanced glycation end products

AKT1

AKT serine/threonine kinase 1

APP

amyloid beta precursor protein

CASP3

Caspase-3

CASP8

Caspase-8

CCND1

cyclin D1

EDN1

endothelin 1

ERBB2

erb-b2 receptor tyrosine kinase 2

ESR1

estrogen receptor 1

GABA

γ-aminobutyric acid

GABAAR

Gamma-aminobutyric acid A receptor

GABRA1

Gamma-aminobutyric acid receptor subunit alpha-1

GABRB2

Gamma-aminobutyric acid receptor subunit beta-2

GO

gene ontology

GSH-Px

glutathione peroxidase

GSK3B

glycogen synthase kinase 3 beta

HERB

High-throughput Experimental and Reference guided database of traditional Chinese medicine

HIF-1

Hypoxia Inducible Factor-1

HMOX1

heme oxygenase 1

HTR1A

5-hydroxytryptamine receptor 1A

ICAM1

intercellular adhesion molecule 1

IFNG

interferon gamma

IL10

Interleukin 10

IL-1β

interleukin 1 beta

IL2

interleukin 2

IL6

Interleukin 6

iNOS

inducible nitric oxide synthase

KEGG

Kyoto Encyclopedia of Genes and Genomes

MAPK1

mitogen-activated protein kinase 1

MMP2

matrix metallopeptidase 2

MMP9

matrix metallopeptidase 9

MTNR1A

melatonin receptor 1A

MTNR1B

melatonin receptor 1B

NO

nitric oxide

NOS

nitric oxide synthase

NOS2

nitric oxide synthase 2

NOS3

nitric oxide synthase 3

PPARG

peroxisome proliferator activated receptor gamma

PPI

protein–protein interaction

PSAP

Pinghe Sleep Aromatherapy Product

SOD

superoxide dismutase

STRING

Search Tool for Recurring Instances of Neighbouring Genes

TCMSP

Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform

TGFB1

transforming growth factor beta 1

TNF

tumor necrosis factor

TNF-α

tumor necrosis factor alpha

TP53

Tumor Protein p53

VEGFA

vascular endothelial growth factor A

This work was supported by Beijing Technology and Business University Digital Business Platform Project of Beijing Municipal Education Commission (Grant Number:19002024028) and Key Program of the National Natural Science Foundation of China (Grant No.12431009).

The authors have no conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

How to cite this article: Yue L, Jiao Q, Li J, Lu Y, Yi M, He C, Jia Y. Screening natural raw materials and product development for improving insomnia based on network pharmacology and data mining. Medicine 2026;105:4(e47072).

LY and QJ contributed to this article equally.

Contributor Information

Lizhi Yue, Email: [email protected].

Qian Jiao, Email: [email protected].

Junxiang Li, Email: [email protected].

Yi Lu, Email: [email protected].

Meiting Yi, Email: [email protected].

Congfen He, Email: [email protected].

References

[1]The sleep disorder study group of Chinese Medical Association Neuropathy Branch. Guidelines for the diagnosis and treatment of adult insomnia in China (2017). Chin J Neurol. 2018;51:324–35.[2]Zhao ZX, Zhang HZ. More attention should be paid to sleep. Chin J Neurol. 2011;44:3.[3]Palagini L, Hertenstein E, Riemann D, Nissen C. Sleep, insomnia and mental health. J Sleep Res. 2022;31:1–17.[4]Laugsand LE, Strand LB, Vatten LJ, et al. Insomnia symptoms and risk for unintentional fatal injuries – the HUNT Study. Sleep. 2014;37:1777–86. [5]Perlis ML, Posner D, Riemann D, Bastien CH, Teel J, Thase M. Insomnia. Lancet. 2022;400:1047–60. [6]Perlis ML, Pigeon WR, Grandner MA, et al. Why treat insomnia? J Prim Care Commun Health. 2021;12:21501327211014084.[7]Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest. 2015;147:1179–92. [8]Qian YY, Li Q, Li SN, et al. Chinese fragrance culture and aromatherapy guided by traditional Chinese medicine. Jiangxi J Tradit Chin Med. 2017;48:8–11.[9]Song X, Jiang WY, Zhu Z, et al. Discussion on insomnia health-preserving and adjusting of traditional Chinese medicine based on traditional fragrant culture. China J Tradit Chin Med Pharmacy. 2021;36:6462–4.[10]Zhou Y, Guo LQ, Liu X, et al. Study on the mechanism of Zhufuling in insomnia based on networkpharmacology, molecular docking and experimental verification. Nat Prod Res Dev. 2021;33:114–26.[11]Dan W, Liu J, Guo X, et al. Study on medication rules of traditional Chinese medicine against antineoplastic drug-induced cardiotoxicity based on network pharmacology and data mining. Evid based Compl Alt. 2020;2020:1–15.[12]Amin M, Gragnoli C. Melatonin receptor 1A (MTNR1A) gene linkage and association to type 2 diabetes in Italian families. Eur Rev Med Pharmacol Sci. 2023;27:4688–92. [13]Postolache TT, Al Tinawi QM, Gragnoli C. The melatonin receptor genes are linked and associated with the risk of polycystic ovary syndrome. J Ovarian Res. 2024;17:1–4. [14]Lei MY, Di R, Liu QY, et al. Advance about molecular genetics of Melatonin Receptor 1A Gene (MTNR1A). J Agricultural Biotechnol. 2015;23:388–96.[15]Ebisawa T, Kajimura N, Uchiyama M, et al. Alleic variants of human melatonin 1a receptor: function and prevalence in subjects with circadian rhythm sleep disorders. Biochem Biophys Res Commun. 1999;262:832–7. [16]Park HJ, Park JK, Park HJ, et al. Association of polymorphism in the promoter of the melatonin receptor 1A gene with schizophrenia and with insomnia symptoms in schizophrenia patients. J Mol Neurosci. 2011;45:304–8. [17]Comai S, Gobbi G. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci. 2014;39:6–21. [18]Piszczek L, Piszczek A, Kuczmanska J, Audero E, Gross CT. Modulation of anxiety by cortical serotonin 1A receptors. Front Behav Neurosci. 2015;9:1–10. [19]Papageorgiou L, Christou E, Louka E, et al. ADRA2B and HTR1A: an updated study of the biogenic amine receptors reveals novel conserved motifs which play key role in mental disorders. Adv Exp Med Biol. 2023;1423:79–99. [20]Wu HN, Zhu SY, Zhang LN, Shen BH, Xu LL. Association between 5-HTR1A gene C-1019G polymorphism and antidepressant response in patients with major depressive disorder: a meta-analysis. World J Psychiatry. 2024;14:1573–82. [21]Wang P, Xin SY, Wang Z, et al. Chaihu-longgu-muli decoction promotes sleep in mice with insomnia. Trop J Pharm Res. 2023;22:1037–42.[22]Sun Y, Chen Q, Cui W, et al. Six-compound combo remedy ameliorates corticosterone-induced depressive behaviors in mice via targeting 5-hydroxytryptamine receptor 1A signaling. J Leukoc Biol. 2024;117:0–13.[23]Yuan M, Zhang J, Shen YJ, et al. Research progress in the GABA receptor mutations related epilepsy. J Neurosci Mental Health. 2023;23:370–5.[24]Li PP, Zhou YY, Gao L, et al. The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABAAR function. Neuroscience. 2024;553:172–84. [25]Horiuchi Y, Nakayama J, Ishiguro H, et al. Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders. Biol Psychiatry. 2004;55:40–5. [26]Zhu B, Chen CS, Xue G, et al. The GABRB1 gene is associated with thalamus volume and modulates the association between thalamus volume and intelligence. Neuroimage. 2014;102:756–63. [27]Chen X, Zhou YN, Lu XZ, et al. Cognitive dysfunction in schizophrenia patients caused by downregulation of γ-aminobutyric acid receptor subunits. World J Psychiatry. 2024;14:784–93. [28]Song P, Zhang Y, Ma G, Zhang Y, Zhou A, Xie J. Gastrointestinal absorption and metabolic dynamics of jujuboside A, a saponin derived from the seed of Ziziphus jujuba. J Agric Food Chem. 2017;65:8331–9. [29]Xu SY, Liu XB, Lu JX, et al. Research progress on antitumor mechanism of active components in Astragali Radix. Chin Tradit Herbal Drugs. 2022;53:7613–23.[30]Dinman GE, Ayta Z, Çaliş I. Turkish astragalus species: botanical aspects, secondary metabolites, and biotransformation. Planta Med. 2025;91:40. [31]Li CX, Liu Y, Zhang YZ, et al. Astragalus polysaccharide: a review of its immunomodulatory effect. Arch. Pharm. Res. 2022;45:367–89. [32]Li M, Wang J, He QY, et al. Compatibility Law of Chinese patent medicine of treating insomnia recorded in pharmacopeia of the People’s Republic of China. J Tradit Chin Med. 2016;57:5.[33]Wang JC, Song X, Yang S, et al. Comparative study of astragalus injection and Dengzhanxixin injection in treatment of insomnia with cardiovascular diseases and cerebrovascular diseases. Clin Focus. 2005;20:2.[34]Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China: VoⅠⅠ. China Medical Science Press, 2020;178–9.[35]Wang ZH, Guo QM, Zhou FQ. Progress in chemical composition pharmacological functions development and utilization of phragmites communis trin. J Liaoning Univ Tradit Chin Med. 2014;16 :81–3.[36]Qing T, Gao ZJ, Su YF, et al. Chemical constituents from Phragmites communis and their antioxidant andα-glucosidase inhibitory activities. Chin Tradit Patent Med. 2022;44:798–06.[37]Xu WR, Wan WR, Fu JL, et al. Research progress of zhuang medicine and its chemical components against virus. Modernization Tradit Chin Med Materia Medica World Sci Technol. 2023;25:1296–308.[38]Zhao XJ, Yu HW, Yang YZ, et al. Polydatin prevents fruc- tose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 2018;18:124–37. [39]Lv R, Du L, Zhang L, Zhang Z. Polydatin attenuates spinal cord injury in rats by inhibiting oxidative stress and microglia apoptosis via Nrf2/HO-1 pathway. Life Sci. 2019;217:119–27. [40]Liu XL, Wang WW. Polydatin reduces neuronal apoptosis by promoting autophagy in mice with traumatic brain injury. Chi J Histochem Cytochemistry. 2022;31:474–80.[41]Pan J, Wang JK. Research on the efficacy of Panax notoginseng in herbal medicine. China J Chin Materia Medica. 2003;28:520–1.[42]Wu Q, Lin J, Liu YC, et al. Study on traditional effect of Panax notoginseng based on network pharmacology. Chin Tradit Herbal Drugs. 2020;51:3717–27.[43]Liu SH, Xie H, Miao Q, et al. Identification of Panax notoginseng and its homonymous foreign body medicinal materials. J Chin Medicinal Materials. 2022;45:1589–94.[44]Huang CJ. Flora of China [M]. Science Press, 1997;43(2):65–6.[45]Wei ST, Liu YQ, Huang J, et al. Research progress of chemical component, medicinal efficacy and liver toxicity of fructus evodiae. World Chin Med. 2020;15:3580–3585,3592.[46]Hu MM, Liu QF, Zang XH, et al. Rutaecarpine inhibits LPS-induced inflammation of microglia BV2 cells and improves learning and memory impairment in neuroinflammatory mice. Chin Arch Tradit Chin Med. 2021;39:110267–5268.[47]Yan CL, Zhang J, Gao YQ, et al. Effects of rutaecarpine on cerebral ischemia-reperfusion in mice and its mechanisms. Chin J Exp Tradit Med Formulae. 2013;19:264–6.
PDF
Loading PDF...

Figures

Network pharmacology target identification for natural raw materials with potential efficacy against insomnia, showing compound-target interactions.

Figure 1.

Network pharmacology target identification for natural raw materials with potential efficacy against insomnia, showing compound-target interactions.

diagram
Protein-protein interaction network of the identified targets shared between selected aromatherapy compounds and insomnia-related pathways.

Figure 2.

Protein-protein interaction network of the identified targets shared between selected aromatherapy compounds and insomnia-related pathways.

diagram
Gene Ontology or KEGG pathway enrichment analysis for the insomnia-related targets of the screened natural aromatic compounds.

Figure 3.

Gene Ontology or KEGG pathway enrichment analysis for the insomnia-related targets of the screened natural aromatic compounds.

chart
Molecular docking visualization showing binding interactions between the top candidate aromatic compounds and key insomnia-related protein targets.

Figure 4.

Molecular docking visualization showing binding interactions between the top candidate aromatic compounds and key insomnia-related protein targets.

diagram
Data mining results revealing patterns in traditional formulations and compound combinations historically used for improving sleep quality.

Figure 5.

Data mining results revealing patterns in traditional formulations and compound combinations historically used for improving sleep quality.

chart
Compound screening and selection criteria diagram for developing the aromatherapy product formulation for insomnia management.

Figure 6.

Compound screening and selection criteria diagram for developing the aromatherapy product formulation for insomnia management.

flowchart
Formulation development process and quality assessment of the final aromatherapy product designed for improving insomnia.

Figure 7.

Formulation development process and quality assessment of the final aromatherapy product designed for improving insomnia.

diagram
In vitro or preliminary efficacy testing results for the developed aromatherapy formulation targeting insomnia improvement.

Figure 8.

In vitro or preliminary efficacy testing results for the developed aromatherapy formulation targeting insomnia improvement.

chart
Safety or cytotoxicity evaluation data for the natural raw materials selected for the insomnia aromatherapy product.

Figure 9.

Safety or cytotoxicity evaluation data for the natural raw materials selected for the insomnia aromatherapy product.

chart
Comprehensive pharmacological network integrating all identified compound-target-pathway relationships for the insomnia-focused natural product.

Figure 10.

Comprehensive pharmacological network integrating all identified compound-target-pathway relationships for the insomnia-focused natural product.

diagram
Summary of the optimized aromatherapy formulation composition and its proposed multi-target mechanism for improving sleep quality.

Figure 11.

Summary of the optimized aromatherapy formulation composition and its proposed multi-target mechanism for improving sleep quality.

diagram

Tables

Table 1

Information of potential targets.

Gene symbolUniprot IDProtein name
MTNR1AP48039Melatonin receptor type 1A
MTNR1BP49286Melatonin receptor type 1B
HTR1AP089085-Hydroxytryptamine receptor 1A
GABRA1P14867Gamma-aminobutyric acid receptor subunit alpha-1
GABRB2P47870Gamma-aminobutyric acid receptor subunit beta-2

Table 2

Notes on compounds associated with the target MTNR1A.

NumberCompound IDCompound name
1HBIN014272Absinthin
2HBIN014467Acetylcholine
3HBIN014685Adeninenucleoside
4HBIN015253Allyl isothiocyanate
5HBIN021262Colchine
6HBIN021605Coumari
7HBIN021608Coumarin
8HBIN021843Cucurbitacin
9HBIN024964Elaterin
10HBIN026267Evodin
11HBIN030814Isohumulone A
12HBIN036930Nigakilactone D
13HBIN037286(−)-Noradrenaline
14HBIN037638Obaculactone
15HBIN037644Obakulactone
16HBIN043778Serotonine

Table 3

Notes on compounds associated with the target MTNR1B.

NumberCompound IDCompound name
1HBIN014272Absinthin
2HBIN014467Acetylcholine
3HBIN014685Adeninenucleoside
4HBIN015253Allyl isothiocyanate
5HBIN021262Colchine
6HBIN021605Coumari
7HBIN021608Coumarin
8HBIN021843Cucurbitacin
9HBIN024964Elaterin
10HBIN026267Evodin
11HBIN030814Isohumulone A
12HBIN036930Nigakilactone D
13HBIN037286(−)-Noradrenaline
14HBIN037638Obaculactone
15HBIN037644Obakulactone
16HBIN043778Serotonine

Table 4

Notes on compounds associated with the target HTR1A.

NumberCompound IDCompound Name
1HBIN00153814-O-cinnamoylneoline
2HBIN0019771,7,8,10,11,12,13,14,15,17,-Decahydro-decahydro-17-(2-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2H-cyclopenta [α] penanthrene-3(6H,9H,14H)-one
3HBIN0083483-Buten-2-one,4-(2,6,6-trimethyl-1-cyclohexen-1-yl)
4HBIN0117715-Methoxy-n-methyltryptamine
5HBIN014272Absinthin
6HBIN014467Acetylcholine
7HBIN015253Allyl isothiocyanate
8HBIN015834Amentoflavone
9HBIN017334Atropine
10HBIN020107Cephalin
11HBIN020174Cetylic acid
12HBIN021250Coixan A
13HBIN021252Coixan C
14HBIN021262Colchine
15HBIN021605Coumari
16HBIN021608Coumarin
17HBIN021843Cucurbitacin
18HBIN022519Cytidine
19HBIN024964Elaterin
20HBIN025875Ethyl aldehyde
21HBIN026267Evodin
22HBIN026399Fat
23HBIN027219Ganoderenic acid A
24HBIN027382Gastrin
25HBIN028518Guanine (1,7-dihydro-form)
26HBIN029342Hexose
27HBIN030047Immune globulin from
28HBIN030814Isohumulone A
29HBIN032185Kikemanine
30HBIN034423Mannose-B
31HBIN034776Mescaline
32HBIN035055Methyl-7-epiganoderate
33HBIN036930Nigakilactone d
34HBIN037061N-methyl-2-β-Hydroxypropyl piperidine
35HBIN037099(+)-N-methyl laurotetanine
36HBIN037100N-methyllaurotetanine
37HBIN037138N,N-dimethyl-5-methoxy tryptamine
38HBIN037286(−)-Noradrenaline
39HBIN037638Obaculactone
40HBIN037644Obakulactone
41HBIN039018Peanut acid
42HBIN042390(−)-Roemerine
43HBIN043778Serotonine
44HBIN044729Stearate
45HBIN044795Stephanthrine
46HBIN044799Stepholidine
47HBIN045566Tatarine
48HBIN045576TAU

Table 5

Notes on compounds associated with the target GABRB2.

NumberCompound IDCompound name
1HBIN046831Trans-resveratrol
2HBIN030047Immune globulin from
3HBIN022632Dandelion game ethyl alcohol

Table 6

Potential core candidate raw materials of target GABRA1.

NumberMaterialsDegree value
1Fresh ginger128
2Chrysanthemum flower118
3Myrrh110
4Root of Chinese Thorowax102
5Villous amomum fruit99
6Perilla frutescens98
7Coriandri sativi herba91
8Chuanxiong rhizome90
9Peppermint86
10Officinal Magnolia Equivalent plant: Magnolia bilo82
11Leaf of Argy Wormwood77
12All-grass of Haichow Elsholtzia75
13Root and rhizome of Incised Notoptergium73
14All-grass of Fineleaf Schizonepeta70
15Common aucklandia root70
16Root of Ligulilobe sage64
17Root of Divaricate Saposhnikovia64
18Shrub chastetree fruit64
19Medicil evodia fruit60
20Honeysuckle flower60
21Sweet wormwood herb60
22Dried ginger59
23Oily wood of Agalloch Eaglewood58
24Taproot angelica56
25Cassia bark56
26Leafy twigs of Oriental Arborvitae56
27Loquat leaf55
28Fructus corni55
29Combined spicebush root54
30Ginkgo folium54
31Ligustici rhizoma et radix54
32Fruit of Glossy privet53
33Rhizome of Nutgrass Galingale53
34Common cnidium fruit53
35Mulberry leaf51
36Pepper fruit50
37Rubi fructus49
38Pricklyash peel49
39Fruit of seabuckthorn49
40Ginseng49
41Clove48
42Alpiniae officirum rhizome47
43Grassleaf sweetflag rhizome47
44Hempleaf negundo chastetree leaf46
45Pogostemon cablin44
46Frankincense44
47Fortune eupatorium herb43
48Solidaginis herba43
49Zedoray rhizome42
50Fruit of Siberian Cockleblur42

Table 7

Degree value of core targets of PSAP in the treatment of insomnia.

NumberGeneDegree value
1AKT182
2TNF70
3IL668
4CASP366
5TP5362
6VEGFA62
7MMP956
8PPARG54
9NOS352
10IL1052
11APP50
12ERBB250
13CASP850
14EDN148
15MAPK148
16MMP248
17ESR146
18GSK3B46
19CCND146
20HMOX146
21IFNG46
22TGFB146
23ICAM144
24NOS242
25IL242

References

  1. Untitled
  2. Untitled
  3. Untitled
  4. Untitled
  5. Untitled
  6. Untitled
  7. Untitled
  8. Untitled
  9. Untitled
  10. Untitled
  11. Untitled
  12. Untitled
  13. Untitled
  14. Untitled
  15. Untitled
  16. Untitled
  17. Untitled
  18. Untitled
  19. Untitled
  20. Untitled
  21. Untitled
  22. Untitled
  23. Untitled
  24. Untitled
  25. Untitled
  26. Untitled
  27. Untitled
  28. Untitled
  29. Untitled
  30. Untitled
  31. Untitled
  32. Untitled
  33. Untitled
  34. Untitled
  35. Untitled
  36. Untitled
  37. Untitled
  38. Untitled
  39. Untitled
  40. Untitled
  41. Untitled
  42. Untitled
  43. Untitled
  44. Untitled
  45. Untitled
  46. Untitled
  47. Untitled

Used In Evidence Reviews

Similar Papers

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.